USPTO Allows Antibody Genus Claims in Patent Enabled by Integral Molecular's Paratope-PLUS™ CDR-Scanning

Data-Driven Technology Re-establishes a Pathway for Antibody Genus Claims that Meet US Patent Requirements PHILADELPHIA, April 21, 2026 /PRNewswire/ -- Integral Molecular, the industry leader in the discovery and engineering of antibodies against membrane proteins, announces that the...